These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 14512528)

  • 1. Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier.
    Xiang ZQ; Gao GP; Reyes-Sandoval A; Li Y; Wilson JM; Ertl HC
    J Virol; 2003 Oct; 77(20):10780-9. PubMed ID: 14512528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosally delivered E1-deleted adenoviral vaccine carriers induce transgene product-specific antibody responses in neonatal mice.
    Xiang Z; Li Y; Gao G; Wilson JM; Ertl HC
    J Immunol; 2003 Oct; 171(8):4287-93. PubMed ID: 14530353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product.
    Xiang Z; Gao G; Reyes-Sandoval A; Cohen CJ; Li Y; Bergelson JM; Wilson JM; Ertl HC
    J Virol; 2002 Mar; 76(6):2667-75. PubMed ID: 11861833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological insights from genetic vaccines.
    Ertl HC
    Virus Res; 2005 Jul; 111(1):89-92. PubMed ID: 15896407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of non-human primates against rabies with an adenovirus recombinant vaccine.
    Xiang ZQ; Greenberg L; Ertl HC; Rupprecht CE
    Virology; 2014 Feb; 450-451():243-9. PubMed ID: 24503087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of systemic or mucosal immunity to adenovirus on Ad-based Ebola virus vaccine efficacy in guinea pigs.
    Richardson JS; Abou MC; Tran KN; Kumar A; Sahai BM; Kobinger GP
    J Infect Dis; 2011 Nov; 204 Suppl 3():S1032-42. PubMed ID: 21987739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chimpanzee-origin adenovirus vector expressing the rabies virus glycoprotein as an oral vaccine against inhalation infection with rabies virus.
    Zhou D; Cun A; Li Y; Xiang Z; Ertl HC
    Mol Ther; 2006 Nov; 14(5):662-72. PubMed ID: 16797238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of an E1-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus.
    Wang Y; Xiang Z; Pasquini S; Ertl HC
    J Virol; 1997 May; 71(5):3677-83. PubMed ID: 9094641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis.
    Wang C; Dulal P; Zhou X; Xiang Z; Goharriz H; Banyard A; Green N; Brunner L; Ventura R; Collin N; Draper SJ; Hill AVS; Ashfield R; Fooks AR; Ertl HC; Douglas AD
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006870. PubMed ID: 30372438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
    Xiang ZQ; Yang Y; Wilson JM; Ertl HC
    Virology; 1996 May; 219(1):220-7. PubMed ID: 8623532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors.
    McCoy K; Tatsis N; Korioth-Schmitz B; Lasaro MO; Hensley SE; Lin SW; Li Y; Giles-Davis W; Cun A; Zhou D; Xiang Z; Letvin NL; Ertl HC
    J Virol; 2007 Jun; 81(12):6594-604. PubMed ID: 17428852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral vaccination of racoons (Procyon lotor) with baculovirus-expressed rabies virus glycoprotein.
    Fu ZF; Rupprecht CE; Dietzschold B; Saikumar P; Niu HS; Babka I; Wunner WH; Koprowski H
    Vaccine; 1993; 11(9):925-8. PubMed ID: 8212838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chimpanzee adenoviral vector-based rabies vaccine protects beagle dogs from lethal rabies virus challenge.
    Wang X; Fang Z; Xiong J; Yang K; Chi Y; Tang X; Ma L; Zhang R; Deng F; Lan K; Zhou D
    Virology; 2019 Oct; 536():32-38. PubMed ID: 31394410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T helper cell-independent antibody responses to the transgene product of an e1-deleted adenoviral vaccine require NK1.1 T cells.
    Xiang ZQ; Gao GP; Li Y; Wilson JM; Ertl HC
    Virology; 2003 Jan; 305(2):397-405. PubMed ID: 12573585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Novel Vaccines Against Infectious Diseases Based on Chimpanzee Adenoviral Vector.
    Zhang C; Chi Y; Zhou D
    Methods Mol Biol; 2017; 1581():3-13. PubMed ID: 28374240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo.
    Pichla-Gollon SL; Lin SW; Hensley SE; Lasaro MO; Herkenhoff-Haut L; Drinker M; Tatsis N; Gao GP; Wilson JM; Ertl HC; Bergelson JM
    J Virol; 2009 Jun; 83(11):5567-73. PubMed ID: 19279092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration.
    Vos A; Neubert A; Pommerening E; Müller T; Döhner L; Neubert L; Hughes K
    J Gen Virol; 2001 Sep; 82(Pt 9):2191-2197. PubMed ID: 11514729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
    Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH
    Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine adenovirus based rabies vaccines.
    Tordo N; Foumier A; Jallet C; Szelechowski M; Klonjkowski B; Eloit M
    Dev Biol (Basel); 2008; 131():467-76. PubMed ID: 18634509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
    Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
    Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.